logo
Products
Services
Resources
Selection Guides
About
PE/iFluor® 750 Anti-human CD56 Antibody
B-A19
B-A19 is an anti-human monoclonal antibody that targets the CD56 antigen. CD56 (alternatively called NKH1 or NCAM-1) is a single-pass type i membrane protein that is expressed on the surface of cells like NK cells and T cells. CD56 has been associated with important biological processes like axon guidance, especially commissural neuron axon guidance. In addition, it plays a role in essential cellular pathways, for instance, the regulation of semaphorin-plexin signaling pathway and interferon-gamma-mediated signaling pathway. From a research standpoint, it is of biological interest due to its association with essential macromolecules/ligands such as Heparin sulfate. CD56 is a fairly uncommon antibody target, with a little more than 10000 publications in the last decade. Even still, CD56 has a variety of applications in research, often serving as a phenotypic marker for differentiating cell types in flow cytometric applications. This antibody was purified through affinity chromatography and conjugated to PE/iFluor® 750 (ex/em = 566/778 nm). It is compatible with the 561 nm laser and 780/60 nm bandpass filter (for example, as in the Agilent Technologies NovoCyte Advanteon).
product image
product image
CatalogSize
Price
Quantity
105601R025 tests
Price
105601R1100 tests
Price
105601R2500 tests
Price
 
Antibody properties

Other namesLeu-19, NKH1, NCAM1
CloneB-A19
HostMouse
IsotypeIgG1
ReactivityHuman
Spectral properties

Extinction coefficient (cm -1 M -1)
1960000
Excitation (nm)565
Emission (nm)778
Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on May 20, 2026